Answers are grounded in this paper and cite their sources.
Background Pediatric septic shock is a leading cause of mortality in critically ill children worldwide, with significantly higher fatality rates in resource-limited regions. Existing treatment guidelines are primarily based on adult sepsis research, creating a critical gap in precise diagnosis and personalized therapy for pediatric patients. This study aimed to identify lactylation-associated gene signatures for pediatric septic shock through multi-omics integration and machine learning-based feature selection, and to validate their diagnostic utility and immune association. Methods Leveraging two gene expression cohorts from the GEO database (training set: GSE26378; validation set: GSE13904), we identified differentially expressed genes (DEGs) between normal and septic shock samples, focusing on 332 lactylation-related genes curated from literature. Candidate genes were obtained by intersecting DEGs with lactylation-related genes. Subsequently, least absolute shrinkage and selection operator (LASSO) regression, Random Forest (RF), and Support Vector Machine (SVM) algorithms were applied for feature selection to screen core candidate genes, yielding a consensus gene set. The diagnostic performance of each selected gene was evaluated individually by ROC curve analysis based on its expression level. Immune cell infiltration profiles were assessed using CIBERSORT based on the LM22 signature matrix. Key findings were experimentally validated via quantitative real-time PCR (qPCR) and enzyme-linked immunosorbent assay (ELISA) in peripheral blood samples from pediatric septic shock patients and age-matched healthy controls. Results A total of 785 DEGs (528 upregulated, 257 downregulated) were identified, with functional enrichment analysis revealing significant involvement in immune regulation, vesicle transport, and inflammatory signaling pathways. Machine learning-based feature selection identified seven lactylation-related upregulated/downregulated genes (S100A11, ENO1, LGALS1, H2BC5, PPP1CB, LRPPRC, ALDH1A1), among which four upregulated genes (S100A11, H2BC5, LGALS1, ENO1) demonstrated consistent diagnostic performance (area under the receiver operating characteristic curve [AUC] > 0.75) across training and validation cohorts. Decision curve analysis further supported their potential clinical utility. These genes were closely associated with immune cell infiltration patterns, as evidenced by subgroup analyses and butterfly plots. qPCR and ELISA validation confirmed significant upregulation of S100A11, H2BC5, LGALS1, and ENO1 at both mRNA and protein levels in pediatric septic shock patients compared to healthy controls. Conclusion S100A11, H2BC5, LGALS1, and ENO1 represent potential lactylation-associated gene signatures for pediatric septic shock, with elevated expression associated with immune microenvironment alterations. These findings provide novel insights for early diagnosis and targeted therapeutic strategies, though prospective multicenter validation is required before clinical translation.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: